Drug Recall


HPS Pharmacies wish to advise that AbbVie Pharmaceuticals, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall of:

Lucrin® Depot Paediatric Injection
 Leuprorelin Acetate 30mg
ARTG 218936

The only affected lot is 1078155.

This recall has been initiated after reports of clumping in the syringe due to incomplete dissolution of the active ingredient powder in the diluent liquid. If an affected product is administered, it may result in incomplete delivery of the medication and a sub-therapeutic dose. It may also lead to increased irritation or reaction at the injection site.

If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all affected products for correction. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or AbbVie Pharmacuticals on 1800 043 460.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates